Patents by Inventor Hideo Nishimura
Hideo Nishimura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11956238Abstract: [Problem] Provided is an authorization system capable of reducing a load on a host regarding an invitation procedure in a case where there is a large number of guests or guests are frequently invited, and preventing identity theft or invitation of an unwanted third party.Type: GrantFiled: August 23, 2019Date of Patent: April 9, 2024Assignee: Nippon Telegraph and Telephone CorporationInventors: Yoshihiko Omori, Takao Yamashita, Hideo Nishimura
-
Patent number: 11917076Abstract: [Problem] To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. [Solution] The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.Type: GrantFiled: May 25, 2022Date of Patent: February 27, 2024Assignee: Nippon Telegraph and Telephone CorporationInventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
-
Publication number: 20230263740Abstract: An object of the present invention is to obtain a capsule for treating ulcerative colitis which, when a capsule containing indigo is orally administered, acts more effectively than conventional ones and has less side effects of hepatotoxicity by not easily disintegrating in the stomach and small intestine but only in the large intestine. The present invention relates to a capsule for treating ulcerative colitis which disintegrates locally in the large intestine, comprising a drug-containing content, a protective layer coating the content and a film formed outside the protective layer, which are arranged concentrically, wherein the content is a content in which indigo, which is a drug for treating ulcerative colitis, is dispersed or dissolved, and the film is locally disintegrated in the large intestine.Type: ApplicationFiled: May 2, 2023Publication date: August 24, 2023Inventors: Takanori KANAI, Hideo NISHIMURA, Tomoyuki KOYAMA, Takuhiko ADACHI, Hiroyuki HAYAKAWA
-
Patent number: 11595844Abstract: A plant system includes: an access node connected to a network; a plurality of controllers configured to perform distributed control on a plurality of field devices provided in a plant; and a wireless communication unit provided in each group of a plurality of groups into which the plurality of controllers are grouped and connected to each controller in the corresponding group via a wired connection, and configured to connect each controller to the access node via a wireless connection.Type: GrantFiled: October 5, 2020Date of Patent: February 28, 2023Assignee: Yokogawa Electric CorporationInventor: Hideo Nishimura
-
Patent number: 11483159Abstract: [Problem] To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. [Solution] The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.Type: GrantFiled: February 5, 2019Date of Patent: October 25, 2022Assignee: Nippon Telegraph and Telephone CorporationInventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
-
Publication number: 20220286297Abstract: To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.Type: ApplicationFiled: May 25, 2022Publication date: September 8, 2022Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
-
Publication number: 20220286296Abstract: [Problem] To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. [Solution] The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.Type: ApplicationFiled: May 25, 2022Publication date: September 8, 2022Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
-
Patent number: 11424915Abstract: [Problem] A terminal registration system and a terminal registration method that enable the number of communication operations between terminals to be reduced are provided.Type: GrantFiled: August 1, 2019Date of Patent: August 23, 2022Assignee: Nippon Telegraph and Telephone CorporationInventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura
-
Publication number: 20210320924Abstract: [Problem] Provided is an authorization system capable of reducing a load on a host regarding an invitation procedure in a case where there is a large number of guests or guests are frequently invited, and preventing identity theft or invitation of an unwanted third party.Type: ApplicationFiled: August 23, 2019Publication date: October 14, 2021Inventors: Yoshihiko Omori, Takao Yamashita, Hideo Nishimura
-
Publication number: 20210320790Abstract: [Problem] A terminal registration system and a terminal registration method that enable the number of communication operations between terminals to be reduced are provided.Type: ApplicationFiled: August 1, 2019Publication date: October 14, 2021Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura
-
Publication number: 20210136621Abstract: A plant system includes: an access node connected to a network; a plurality of controllers configured to perform distributed control on a plurality of field devices provided in a plant; and a wireless communication unit provided in each group of a plurality of groups into which the plurality of controllers are grouped and connected to each controller in the corresponding group via a wired connection, and configured to connect each controller to the access node via a wireless connection.Type: ApplicationFiled: October 5, 2020Publication date: May 6, 2021Inventor: Hideo NISHIMURA
-
Publication number: 20210058256Abstract: [Problem] To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. [Solution] The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.Type: ApplicationFiled: February 5, 2019Publication date: February 25, 2021Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
-
Publication number: 20200352868Abstract: An object of the present invention is to obtain a capsule for treating ulcerative colitis which, when a capsule containing indigo is orally administered, acts more effectively than conventional ones and has less side effects of hepatotoxicity by not easily disintegrating in the stomach and small intestine but only in the large intestine. The present invention relates to a capsule for treating ulcerative colitis which disintegrates locally in the large intestine, comprising a drug-containing content, a protective layer coating the content and a film formed outside the protective layer, which are arranged concentrically, wherein the content is a content in which indigo, which is a drug for treating ulcerative colitis, is dispersed or dissolved, and the film is locally disintegrated in the large intestine.Type: ApplicationFiled: January 16, 2019Publication date: November 12, 2020Inventors: Takanori KANAI, Hideo NISHIMURA, Tomoyuki KOYAMA, Takuhiko ADACHI, Hiroyuki HAYAKAWA
-
Patent number: 8640873Abstract: A plastic ampule comprising a body portion, a head portion provided continuously to the mouth portion of the body portion through a cut-off portion, and a knob portion provided continuously to the head portion the ampule being unsealed by twisting the knob portion with fingers to cut the head portion off the mouth portion, wherein the hollow portion in the head portion is formed in the shape of a bowl. Since the hollow portion is formed in the shape of a bowl, content liquid remaining in the hollow portion can be discharged easily, the plastic ampule can be unsealed easily, and the content liquid remaining in the hollow portion is not scattered easily at the time of unsealing.Type: GrantFiled: April 23, 2009Date of Patent: February 4, 2014Assignee: Nippon Zoki Pharamaceutical Co., Ltd.Inventors: Hideshi Nakano, Hideo Nishimura
-
Patent number: 8580557Abstract: The present invention relates to a casein hydrolysate containing free amino acids and in vivo indigestible peptides having minimally suppressed in vivo enzymatic digestibility, and expected to express functions, such as hypotensive effect, in living organism, and to a method for preparing such a hydrolysate, and use thereof. The casein hydrolysate of the present invention contains free amino acids and peptides, such as in vivo indigestible peptides including Xaa-Pro and Xaa-Pro-Pro, obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, and has ACE inhibitory activity or hypotensive effect.Type: GrantFiled: September 1, 2010Date of Patent: November 12, 2013Assignee: Calpis Co., Ltd.Inventors: Naoyuki Yamamoto, Seiichi Mizuno, Takanobu Gotou, Keiichi Matsuura, Tadashi Shinoda, Hideo Nishimura
-
Publication number: 20110082281Abstract: The present invention relates to a casein hydrolysate containing free amino acids and in vivo indigestible peptides having minimally suppressed in vivo enzymatic digestibility, and expected to express functions, such as hypotensive effect, in living organism, and to a method for preparing such a hydrolysate, and use thereof. The casein hydrolysate of the present invention contains free amino acids and peptides, such as in vivo indigestible peptides including Xaa-Pro and Xaa-Pro-Pro, obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, and has ACE inhibitory activity or hypotensive effect.Type: ApplicationFiled: September 1, 2010Publication date: April 7, 2011Applicant: CALPIS CO., LTD.Inventors: Naoyuki Yamamoto, Seiichi Mizuno, Shingo Nishimura, Hideo Nishimura, Takanobu Gotou, Keiichi Matsuura, Tadashi Shinoda
-
Publication number: 20110031157Abstract: A plastic ampule comprising a body portion, a head portion provided continuously to the mouth portion of the body portion through a cut-off portion, and a knob portion provided continuously to the head portion the ampule being unsealed by twisting the knob portion with fingers to cut the head portion off the mouth portion, wherein the hollow portion in the head portion is formed in the shape of a bowl. Since the hollow portion is formed in the shape of a bowl, content liquid remaining in the hollow portion can be discharged easily, the plastic ampule can be unsealed easily, and the content liquid remaining in the hollow portion is not scattered easily at the time of unsealing.Type: ApplicationFiled: April 23, 2009Publication date: February 10, 2011Applicant: NIPPON ZOKI PHARMACEUTICAL CO., LTD.Inventors: Hideshi Nakano, Hideo Nishimura
-
Publication number: 20070299014Abstract: The present invention relates to a casein hydrolysate containing free amino acids and in vivo indigestible peptides having minimally suppressed in vivo enzymatic digestibility, and expected to express functions, such as hypotensive effect, in living organism, and to a method for preparing such a hydrolysate, and use thereof. The casein hydrolysate of the present invention contains free amino acids and peptides, such as in vivo indigestible peptides including Xaa-Pro and Xaa-Pro-Pro, obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, and has ACE inhibitory activity or hypotensive effect.Type: ApplicationFiled: July 30, 2004Publication date: December 27, 2007Applicant: CALPIS CO., LTD.Inventors: Naoyuki Yamamoto, Seiichi Mizuno, Shingo Nishimura, Hideo Nishimura, Takanobu Gotou, Keiichi Matsuura, Tadashi Shinoda
-
Publication number: 20070122451Abstract: The present invention provides novel in vivo indigestible peptides that are highly absorbable and hardly digestible in living organism when administered orally or through other route, and expected to effectively exhibit functions, such as hypotensive effect, in living organism, and ACE inhibitors prepared with the peptides, and medicine or functional food expected to effectively exhibit hypotensive effect in living organism. The in vivo indigestible peptides are dipeptides or tripeptides having Pro at the carboxyl terminals, selected from the group consisting of Ile-Pro, Glu-Pro, Arg-Pro, Gln-Pro, Met-Pro, and Ser-Pro-Pro.Type: ApplicationFiled: July 30, 2004Publication date: May 31, 2007Applicant: Calpis Co., Ltd.Inventors: Naoyuki Yamamoto, Seiichi Mizuno, Shingo Nishimura, Hideo Nishimura, Takanobu Gotou, Keiichi Matsuura
-
Patent number: 6803398Abstract: An olefin-based thermoplastic elastomer composition comprising a thermoplastic elastomer blended with other resins and rubbers is provided. The thermoplastic elastomer contains polypropylene resin and an olefin-based copolymer rubber, and optionally, a linear polyethylene resin, and the thermoplastic elastomer has been crosslinked to a gel content of 95% or higher. A polyolefin resin, an olefin-based copolymer rubber and a softening agent are further blended with optional inorganic filler to provide the olefin-based thermoplastic elastomer composition. This composition is excellent in oil resistance and extrudability, and well-adapted for use as an energy-saving, resources-saving elastomer in applications including surface or skin material in autoparts, industrial mechanical parts, electric and electronic parts, and construction materials.Type: GrantFiled: February 28, 2000Date of Patent: October 12, 2004Assignees: Mitsui Chemicals, Inc., Toyota Motor CorporationInventors: Yuichi Ito, Hiroyasu Yamaoka, Akira Uchiyama, Chika Kako, Hideo Nishimura, Junzo Ukai